Founded on September 6, 2016, Shanghai Nortion Medical Technology Co., Ltd. is a company in medical technology, focusing on the development and application of "irreversible electroporation (IRE)" technology. The company is committed to advancing IRE technology for conditions requiring high standards of vascular and neurological function protection, as well as providing comprehensive solutions for established indications. Currently, Nortion's main product is Compound Steep Pulse Therapeutic Apparatus (CSPTA) based on the principle of irreversible electroporation technology. This device has not only received registration certificates for prostate cancer and benign prostatic hyperplasia in China but has also obtained CE certification for prostate cancer in the European Union and Breakthrough Device Designation from the FDA for prostate cancer. The results of a direct clinical study on CSPTA for prostate cancer were published in JAMA Surgery, a top journal in the field of surgery.

Nortion is recognized as a national 'Specialized, Expert, Unique, Innovative' enterprise in China and is classified as a national high-tech company. It is also designated as a 'Specialized, Expert, Unique, Innovative' enterprise and a patent pilot company in Shanghai, as well as an R&D institution in the Pudong New Area. Nortion has been honored with several awards, including the first prize for scientific and technological progress from the Ministry of Education of the People's Republic of China in 2022, the Excellence Award in the National Competition of the 11th China Innovation and Entrepreneurship Competition, a spot among the top 50 enterprises with the most investment value potential in Shanghai in 2022, the second prize in the 2024 "Maker China" Innovation and Entrepreneurship Competition, and the second prize of Huaxia Medical Science and Technology awarded by the Ministry of Science and Technology of China.

Located in the Shanghai Pudong International Medical Park, Nortion's production and R&D base features a 10,000-class clean workshop, a high-standard assembly workshop designed in accordance with GMP and ISO13485 standards, a comprehensive testing laboratory, and a standardized quality management system.

Relying on its achievements in independent innovation, the company had applied for 108 intellectual property rights by the end of 2023, 60 of which have been granted, including 34 national invention patents. Since 2016, Nortion has been approved and completed a project titled "National Key R&D Program - Major Special Project for the R&D of Digital Diagnosis and Treatment Equipment".